sema cagrilintide Novo Nordisk has officially filed for FDA approval of CagriSema, a powerful new once-weekly injection that combines a GLP-1 receptor agonist with an amylin analogue, setting the stage for the next major Cagrilintide and semaglutide act individually

Aug 9 2021;doi:10.1111/andr.13090

GHK-Cu and Skin Biology Research In vitro studies with human adult dermal fibroblasts found that GHK-Cu at concentrations of 0.01, 1, and 100 nM increased production of both elastin and collagen, with all concentrations increasing TIMP1 a key inhibitor of matrix metalloproteinases

To date, therapies to treat intervertebral disc degeneration are limited, involving broad-spec anti-inflammatory drugs, which have undesirable side effects, or surgeries that are invasive, risky, and require long recovery times

With a simple blood test, we can easily check your Vitamin B12 levels and determine if you have a deficiency and may benefit from supplementation

At the gastric level, cagrilintide significantly slows gastric emptying and food transit through the gastrointestinal tract

doi: 10.1016/j.apsb.2021.07.028